NEW HEAD OF ANALYTICAL SERVICES FOR PENN PHARMA - 14 Sep 2009

Integrated global pharmaceutical drug developer and manufacturer based in South Wales, Penn Pharma, has appointed Tony Engel as Head of Analytical Services.

Tony, who has considerable international pharmaceutical experience, joins Penn Pharma from Catalent Pharma Solutions in Swindon. During his 22 years at Catalant Pharma Solutions, Tony has been involved in analytical development before moving into management of the company’s research & development and commercial testing laboratory.

Tony will be using his knowledge and operational expertise to manage a team of 45 analytical chemists to provide clients with reputable analytical support across a wide variety of clinical and commercial product development programmes.

Tony Engel said:

"Penn’s analytical development has over 25 year’s experience in provision of practical, effective and compliant analytical solutions for its clients and I am looking forward to building on this reputation for excellence in my new role."

Peter George added:

"Tony joins Penn Pharma at a very exciting time. We have seen the company expand worldwide in recent years and Tony’s experience will greatly assist us in continuing to grow our market base by providing our clients with bespoke services and solutions that differentiate us from the competition."

Recent Press

PENN PHARMA ANNOUNCES £14 MILLION POUND INVESTMENT IN HIGH CONTAINMENT OPERATIONS
28 Feb 2012
Pharmaceutical manufacturer and developer, Penn Pharma, has today, 28th February 2012, announced a £14 million investment in its South Wales UK facility to strengthen its offering for global supply and further build on the company’s established high tech manufacturing capabilities.